Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
European Journal of Epidemiology|June 18, 2009
Diverging trends in cardiovascular morbidity and mortality in a low risk populationTheodore Chimonas, Irene Fanouraki, Evangelos N Liberopoulos, et al.
Current Medical Research and Opinion|November 11, 2003
Statins and renal function in patients with diabetes mellitusVasilios G Athyros, Athanasios A Papageorgiou, Moses Elisaf, et al.
Lipids|April 12, 2007
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesVasilis Tsimihodimos, Irene Gazi, Christina Kostara, et al.
Oncology|March 14, 2008
Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinomaVasilios Tzovaras, Evangelos N Liberopoulos, Aikaterini Zioga, et al.
Current Medical Research and Opinion|August 9, 2005
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsVasilios G Athyros, Emmanuel S Ganotakis, Moses Elisaf, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2007
Electrolyte disturbances in patients with hyponatremiaGeorge Liamis, Zoi Mitrogianni, Evangelos N Liberopoulos, et al.
Atherosclerosis|February 13, 2016
High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndromeFotios Barkas, Moses Elisaf, Evangelos Liberopoulos, et al.
Atherosclerosis|January 12, 2010
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?Niki Katsiki, Konstantinos Tziomalos, Yiannis Chatzizisis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 1, 2006
Should atenolol still be recommended as first-line therapy for primary hypertension?Asterios Karagiannis, Vasilios G Athyros, Athanasios Papageorgiou, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 27, 2018
SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipidsSempastian Filippas-Ntekouan, Vasilios Tsimihodimos, Theodosios Filippatos, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
European Journal of Epidemiology|June 18, 2009
Diverging trends in cardiovascular morbidity and mortality in a low risk populationTheodore Chimonas, Irene Fanouraki, Evangelos N Liberopoulos, et al.
Current Medical Research and Opinion|November 11, 2003
Statins and renal function in patients with diabetes mellitusVasilios G Athyros, Athanasios A Papageorgiou, Moses Elisaf, et al.
Lipids|April 12, 2007
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesVasilis Tsimihodimos, Irene Gazi, Christina Kostara, et al.
Oncology|March 14, 2008
Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinomaVasilios Tzovaras, Evangelos N Liberopoulos, Aikaterini Zioga, et al.
Current Medical Research and Opinion|August 9, 2005
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsVasilios G Athyros, Emmanuel S Ganotakis, Moses Elisaf, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2007
Electrolyte disturbances in patients with hyponatremiaGeorge Liamis, Zoi Mitrogianni, Evangelos N Liberopoulos, et al.
Atherosclerosis|February 13, 2016
High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndromeFotios Barkas, Moses Elisaf, Evangelos Liberopoulos, et al.
Atherosclerosis|January 12, 2010
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?Niki Katsiki, Konstantinos Tziomalos, Yiannis Chatzizisis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 1, 2006
Should atenolol still be recommended as first-line therapy for primary hypertension?Asterios Karagiannis, Vasilios G Athyros, Athanasios Papageorgiou, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 27, 2018
SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipidsSempastian Filippas-Ntekouan, Vasilios Tsimihodimos, Theodosios Filippatos, et al.
Pageof 25